Jiang, H., Xu, M., Li, L., Grierson, P., Dodhiawala, P., Highkin, M., . . . Lim, K. (2018). Concurrent HER or PI3K Inhibition Potentiates the Anti-tumor Effect of ERK Inhibitor Ulixertinib in Preclinical Pancreatic Cancer Models. Mol Cancer Ther.
Trích dẫn kiểu ChicagoJiang, Hongmei, et al. "Concurrent HER or PI3K Inhibition Potentiates the Anti-tumor Effect of ERK Inhibitor Ulixertinib in Preclinical Pancreatic Cancer Models." Mol Cancer Ther 2018.
Trích dẫn MLAJiang, Hongmei, et al. "Concurrent HER or PI3K Inhibition Potentiates the Anti-tumor Effect of ERK Inhibitor Ulixertinib in Preclinical Pancreatic Cancer Models." Mol Cancer Ther 2018.
Cảnh báo: Các trích dẫn này có thể không phải lúc nào cũng chính xác 100%.